KA
ZBH icon

KLCM Advisors’s Zimmer Biomet ZBH Stock Holding History

KLCM Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Sell
128,250
-2,891
-2% -$265K 0.98% 28
2025
Q4 		$11.8M Buy
131,141
+58,427
+80% +$5.54M 1.01% 28
2025
Q3 		$7.16M Sell
72,714
-280
-0.4% -$27.7K 0.71% 33
2025
Q2 		$6.66M Sell
72,994
-1,907
-3% -$184K 0.71% 34
2025
Q1 		$8.48M Buy
74,901
+818
+1% +$87.5K 0.99% 31
2024
Q4 		$7.83M Buy
+74,083
New +$7.95M 0.91% 31

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KLCM Advisors's ZBH Position: Q1 2026 in Review

KLCM Advisors reduced its Zimmer Biomet (ZBH) stake by 2.2% in Q1 2026, selling an estimated $265K and leaving 128,250 shares worth $11.6M. The position accounts for 0.98% of the portfolio, ranked #28.

KLCM Advisors first reported a position in ZBH in Q4 2024 and has held it in 6 quarters since. The position peaked at $11.8M in Q4 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • KLCM Advisors held 128,250 shares of Zimmer Biomet worth $11.6M as of Q1 2026.
  • KLCM Advisors sold 2,891 Zimmer Biomet shares in Q1 2026, an estimated $265K.
  • Zimmer Biomet made up 0.98% of KLCM Advisors's portfolio in Q1 2026, its #28 holding.
  • KLCM Advisors first reported a position in Zimmer Biomet in Q4 2024 and has held it in 6 quarters since.
  • KLCM Advisors's Zimmer Biomet position peaked at $11.8M in Q4 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on KLCM Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.